These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 38641192)
1. Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study. Hong B; Bea S; You SC; Chang Y; Kim W; Shin JY Am J Med; 2024 Aug; 137(8):742-750.e11. PubMed ID: 38641192 [TBL] [Abstract][Full Text] [Related]
2. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361 [TBL] [Abstract][Full Text] [Related]
3. Efficacy assessment of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention by data mining and machine-learning decision tree approaches. Xue Y; Hu Z; Jing Y; Wu H; Li X; Wang J; Seybert A; Xie X; Lv Q J Clin Pharm Ther; 2020 Oct; 45(5):1076-1086. PubMed ID: 32627223 [TBL] [Abstract][Full Text] [Related]
4. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries. Bianco M; Careggio A; Biolè CA; Quadri G; Quiros A; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solè A; Liebetrau C; Manzano-Fernàndez S; Boccuzzi G; Henriques JPS; Spirito A; Templin C; Wilton SB; Velicki L; Correia L; Rognoni A; Ugo F; Nunez-Gil I; Fujii T; Durante A; Song X; Kawaji T; Alexopoulos D; Huczek Z; Gonzàlez Juanatey JR; Nie SP; Kawashiri MA; Morbiducci U; Dominguez-Rodriguez A; Destefanis P; Luciano A; De Ferrari GM; Varbella F; Montagna L; D'Ascenzo F; Cerrato E Cardiovasc Drugs Ther; 2021 Dec; 35(6):1171-1182. PubMed ID: 34224052 [TBL] [Abstract][Full Text] [Related]
5. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial. Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ; Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203 [TBL] [Abstract][Full Text] [Related]
6. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944 [TBL] [Abstract][Full Text] [Related]
7. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention. Abraham NS; Yang EH; Noseworthy PA; Inselman J; Yao X; Herrin J; Sangaralingham LR; Ngufor C; Shah ND Aliment Pharmacol Ther; 2020 Aug; 52(4):646-654. PubMed ID: 32657466 [TBL] [Abstract][Full Text] [Related]
8. Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention. Zheng W; Li Y; Tian J; Li L; Xie L; Mao Q; Tong W; Zhou D; Azzalini L; Zhao X Biomed Res Int; 2019; 2019():3170957. PubMed ID: 31016189 [TBL] [Abstract][Full Text] [Related]
9. Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction. Ko D; Evans PT; Lin KJ; Pande AN; Cervone A; Lee SB; Cheng S; Tsacogianis T; Glynn RJ; Kim DH J Am Heart Assoc; 2024 Aug; 13(15):e034529. PubMed ID: 39056329 [TBL] [Abstract][Full Text] [Related]
10. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Wang HY; Li Y; Xu XM; Li J; Han YL Chin Med J (Engl); 2018 Sep; 131(17):2017-2024. PubMed ID: 30127210 [TBL] [Abstract][Full Text] [Related]
11. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice. Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845 [TBL] [Abstract][Full Text] [Related]
12. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK; J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138 [TBL] [Abstract][Full Text] [Related]
13. Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. Xi Z; Zhou Y; Zhao Y; Liu X; Liang J; Chai M; Yu Y; Liu W Cardiovasc Drugs Ther; 2020 Apr; 34(2):179-188. PubMed ID: 32140798 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database. Blin P; Dureau-Pournin C; Benichou J; Bonello L; Dallongeville J; Danchin N; Falissard B; Thomas-Delecourt F; Jové J; Lassalle R; Droz C; Moore N Atherosclerosis; 2019 Feb; 281():98-106. PubMed ID: 30658197 [TBL] [Abstract][Full Text] [Related]
16. In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project. Yang N; Liu J; Liu J; Hao Y; Smith JSC; Huo Y; Fonarow GC; Ge J; Morgan L; Ma C; Han Y; Zhao D; Age Ageing; 2022 Nov; 51(11):. PubMed ID: 36413586 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis. Dawwas GK; Dietrich E; Winchester DE; Winterstein AG; Segal R; Park H Pharmacotherapy; 2019 Sep; 39(9):912-920. PubMed ID: 31332815 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention. Wang C; Zheng W; Shaqdan A; Wang C; Qin X; Zhao X; Wang X; Yuan L; Nie S; Liu R Platelets; 2020; 31(3):337-343. PubMed ID: 31043110 [TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System. Coons JC; Iasella CJ; Chanas T; Wang N; Williams K; Boyd A; Lyons J; Eckardt J; Rihtarchik L; Merkel A; Chambers A; Lemon LS; Smith R; Ensor CR Ann Pharmacother; 2017 Aug; 51(8):649-655. PubMed ID: 28438043 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention. Li J; Qiu H; Yan L; Guo T; Wang Y; Li Y; Zheng J; Tang Y; Xu B; Qiao S; Yang Y; Gao R Curr Med Res Opin; 2020 Nov; 36(11):1739-1745. PubMed ID: 32945695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]